Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02511730 · ClinicalTrials.gov registry record · NA

Pilot Mammography Reader Study to Assess Breast Cancer Detection in FFDM Plus DBT Versus FFDM Alone

A NA study, sponsored by Fujifilm Medical Systems USA.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT02511730: Completed NA study, sponsored by Fujifilm Medical Systems USA.

NCT02511730 is a NA study that has completed, run by Fujifilm Medical Systems USA. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02511730, a NA study, has completed, sponsored by Fujifilm Medical Systems USA.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

The purpose of this pilot is to provide credible performance estimate information in order to conduct subsequent reader studies.

Interventions

  • DEVICE FFDM Plus DBT
  • DEVICE FFDM

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2015-06
Est. Completion 2015-08
Phase NA

Sponsor

Fujifilm Medical Systems USA

13 total trials

What the Registry Record Tells You About NCT02511730

The ClinicalTrials.gov registry entry for NCT02511730 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fujifilm Medical Systems USA, which has 13 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which FFDM Plus DBT is the first listed.

NCT02511730 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02511730 about?

NCT02511730 is a clinical study titled "Pilot Mammography Reader Study to Assess Breast Cancer Detection in FFDM Plus DBT Versus FFDM Alone". The purpose of this pilot is to provide credible performance estimate information in order to conduct subsequent reader studies.

What is the current status of trial NCT02511730?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-06. Estimated completion is 2015-08.

What interventions are being tested in trial NCT02511730?

The interventions under investigation include: FFDM Plus DBT (DEVICE), FFDM (DEVICE).

Who is sponsoring clinical trial NCT02511730?

This trial is sponsored by Fujifilm Medical Systems USA, which has 13 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.